Skip to main content

13-09-2019 | Multiple sclerosis | Video

ECTRIMS 2019: Support for newer drug-modifying therapies in initial treatment of paediatric MS

Kristen Krysko gives her findings on the real-world effectiveness of newer and injectable drug-modifying therapies as a guide to which treatments to initiate in children with multiple sclerosis (3:06).

Funding for independent interviews at ECTRIMS 2019 was provided by F.Hoffmann-La Roche Ltd, Basel, Switzerland.